UnitedHealth Board Accepts Andrew Witty’s Resignation

The latest update is out from UnitedHealth ( (UNH) ).

On May 20, 2025, UnitedHealth Group’s Board of Directors accepted the resignation of Andrew Witty as a director, effective immediately. Consequently, Mr. Witty will not seek re-election at the upcoming annual shareholder meeting on June 2, 2025.

The most recent analyst rating on (UNH) stock is a Buy with a $647.00 price target. To see the full list of analyst forecasts on UnitedHealth stock, see the UNH Stock Forecast page.

Spark’s Take on UNH Stock

According to Spark, TipRanks’ AI Analyst, UNH is a Neutral.

UnitedHealth demonstrates solid financial health with significant revenue growth and effective cash flow management, but faces challenges such as declining profitability metrics and bearish technical indicators. Recent corporate events, including the CEO transition and outlook suspension, add to the uncertainty. Despite these near-term challenges, the valuation remains reasonable and the company is well-positioned for long-term growth.

To see Spark’s full report on UNH stock, click here.

More about UnitedHealth

UnitedHealth Group Incorporated operates in the healthcare industry, providing a diverse array of health benefits and services. The company focuses on improving health outcomes and reducing costs through its comprehensive healthcare offerings.

Average Trading Volume: 12,744,033

Technical Sentiment Signal: Sell

Current Market Cap: $286.6B

See more insights into UNH stock on TipRanks’ Stock Analysis page.